Literature DB >> 29342347

A pH-Sensitive Nanosystem Based on Carboxymethyl Chitosan for Tumor-Targeted Delivery of Daunorubicin.

Xueqiong Zhang, Hong Zhang, Liangquan Yin, Rui Hu, Tong Qiu, Yihua Yin, Xiong Xiong, Hua Zheng, Qun Wang.   

Abstract

Nanoparticles, such as polymeric micelles, are currently regarded as effective drug delivery vehicles. In this study, a series of carboxymethyl chitosan/daunorubicin (CMCS/DNR) conjugates with macromolecular carriers of different molecular weights (MWs) were prepared and structurally characterized by Fourier transform infrared spectroscopy (FT-IR) and 1H-NMR spectroscopy. The results indicated that the MWs of the carriers greatly influenced the drug loading capacity. DNR was conjugated to the polymer via an acid-sensitive hydrazone linkage susceptible to hydrolysis at pH 5–6, thereby enabling intracellular DNR release. In aqueous media, the conjugates spontaneously formed nano-sized particles with core–shell structures (CMCS and DNR as the shell and core, respectively). Dynamic light scattering (DLS) and trans-mission electron microscopy (TEM) indicated that the prepared nanoparticles were spherical in shape with diameters of 100–200 nm and had a slight negative surface charge. In addition, in vitro drug release studies demonstrated that the micelles were highly sensitive to mild acidic conditions (pH 5.0) but remained reasonably stable at pH 6.5 and pH 7.4. Importantly, cell counting kit-8 (CCK-8) assays demonstrated that DNR-conjugated nanoparticles exerted a cytotoxic effect on HeLa cells, with the IC50 being approximately 2 times higher than that of free-DNR. Furthermore, confocal laser scanning microscopy (CLSM) revealed that the CMCS-hyd-DNR nanosystem could efficiently deliver and release DNR in the nuclei of cancer cells. Taken together, the developed CMCS based pH-sensitive nanosystem may be a potential drug delivery vehicle for cancer therapy.

Entities:  

Keywords:  Nanoparticles; pH-Sensitive; Polymeric Micelles; Carboxymethyl Chitosan; Daunorubicin

Mesh:

Substances:

Year:  2016        PMID: 29342347     DOI: 10.1166/jbn.2016.2278

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  8 in total

Review 1.  Nanoparticle systems for cancer vaccine.

Authors:  Ru Wen; Afoma C Umeano; Yi Kou; Jian Xu; Ammad Ahmad Farooqi
Journal:  Nanomedicine (Lond)       Date:  2019-02-26       Impact factor: 5.307

2.  Novel nano-microspheres containing chitosan, hyaluronic acid, and chondroitin sulfate deliver growth and differentiation factor-5 plasmid for osteoarthritis gene therapy.

Authors:  Zhu Chen; Shang Deng; De-Chao Yuan; Kang Liu; Xiao-Cong Xiang; Liang Cheng; Dong-Qin Xiao; Li Deng; Gang Feng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Dec.       Impact factor: 3.066

3.  Encapsulation of Anticancer Drugs (5-Fluorouracil and Paclitaxel) into Polycaprolactone (PCL) Nanofibers and In Vitro Testing for Sustained and Targeted Therapy.

Authors:  Sakib Iqbal; Mohammad H Rashid; Ali S Arbab; Mujibur Khan
Journal:  J Biomed Nanotechnol       Date:  2017-04       Impact factor: 4.099

4.  Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl2 Inhibit Melanoma via Regulating Macrophage Polarization and Dendritic Cell Maturation.

Authors:  Xinghan Liu; Yujun Xu; Lijie Yin; Yayi Hou; Shuli Zhao
Journal:  Int J Nanomedicine       Date:  2021-08-21

5.  Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy.

Authors:  Zhou Zhong; Zhong Cheng; Dongyuan Su; Ting Xu; Xiang Li; Fengbo Wu
Journal:  RSC Adv       Date:  2018-10-16       Impact factor: 4.036

Review 6.  Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery.

Authors:  Rajiv Bajracharya; Jae Geun Song; Seung Yun Back; Hyo-Kyung Han
Journal:  Comput Struct Biotechnol J       Date:  2019-09-11       Impact factor: 7.271

7.  Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor.

Authors:  Song Yi Lee; Jin Woo Choi; Jae-Young Lee; Dae-Duk Kim; Hyo-Cheol Kim; Hyun-Jong Cho
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 8.  Nanochitosan: Commemorating the Metamorphosis of an ExoSkeletal Waste to a Versatile Nutraceutical.

Authors:  Iyyakkannu Sivanesan; Manikandan Muthu; Judy Gopal; Nazim Hasan; Syed Kashif Ali; Juhyun Shin; Jae-Wook Oh
Journal:  Nanomaterials (Basel)       Date:  2021-03-23       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.